MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Clinical trials for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental triple therapy aims to tame leukemia without intensive chemo
Disease control Recruiting nowThis phase I trial tests whether adding the experimental drug iadademstat to two standard leukemia medications (azacitidine and venetoclax) is safe and tolerable for adults with newly diagnosed acute myeloid leukemia (AML) who cannot undergo intensive chemotherapy. Iadademstat bl…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo targets tough blood cancers in early trial
Disease control Recruiting nowThis early-stage trial is testing a new drug called cirtuvivint, alone or with another drug combo (ASTX727), in people with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). The goal is to find the safest dose and check for side effects. About 54 participants whose…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for tough blood cancers? early trial launches
Disease control Recruiting nowThis early-stage study tests an experimental drug called APL-4098, alone or with standard treatments, in adults with acute myeloid leukemia (AML) or related blood disorders. The goal is to find a safe dose and see if it shrinks cancer. About 100 people will take part.
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control Recruiting nowThis study tests whether removing a specific type of immune cell (naive T cells) from donor stem cells can prevent chronic graft-versus-host disease (GVHD) in children and young adults with blood cancers. GVHD occurs when donor cells attack the patient's body after a stem cell tr…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New hope for tough leukemia? early trial tests AB8939
Disease control Recruiting nowThis early-phase trial is testing a new drug called AB8939, given daily through a vein, for people with acute myeloid leukemia that has come back or not responded to standard treatments. About 78 participants will receive AB8939, sometimes with another drug called venetoclax. The…
Matched conditions: MYELODYSPLASTIC SYNDROME/ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC